EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Safety and Efficacy of the Modified Vaccinia Ankara–Bavaria Nordic Vaccine Against Mpox in the Real World: Systematic Review and Meta-Analysis

Yi Pang, Demin Cao, Xiaoying Zhu, Qinqin Long, Fengqin Tian, Xidai Long, Yulei Li iD

Viral Immunology · 2024

DOI: 10.1089/vim.2023.0147 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Viral Immunology, 2024. Verfasst von Yi Pang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Science and Technology Department, Youjiang Medical University for Nationalities, Baise, China. Hauptthemen laut MEDLINE: Vaccine Efficacy, Vaccines, Attenuated. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In May 2022, mpox began to spread worldwide, posing a serious threat to human public health. Modified Vaccinia Ankara-Bavaria Nordic (MVA-BN) is a live attenuated orthopoxvirus vaccine that has been authorized by the U.S. Food and Drug Administration as the vaccine of choice for the prevention of mpox. In this study, we conducted a meta-analysis of all currently published literature on the efficacy and safety of the MVA-BN vaccine in the real world, showing that the MVA-BN vaccine is effective and safe, with efficacy of up to 75% with a single dose and up to 80% with a two-dose vaccine. Meanwhile, we found that subcutaneous injection has lower local and systemic adverse events than intradermal injection, regardless of single- or two-dose vaccination, and subcutaneous injection is better tolerated in children, the elderly, or people with underlying medical conditions. These results have important reference value for clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccine EfficacyVaccines, AttenuatedHumansPoxviridae InfectionsVaccinia virusVaccinationInjections, SubcutaneousInjections, IntradermalViral VaccinesOrthopoxvirusChildMpox, Monkeypox

Stichwörter der Autor:innen

MVA–BN vaccineefficacympoxsafety

Substanzen

Vaccines, AttenuatedViral Vaccines

Autor:innen und Institutionen

  • Science and Technology Department, Youjiang Medical University for Nationalities, Baise, China.
  • Clinicopathological Diagnosis & Research Center, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
  • Key Laboratory of Tumor Molecular Pathology of Guangxi Higher Education Institutes, Baise, China.

ORCID-Profile: Yulei Li

Zitieren

APA

Pang, Y., Cao, D., Zhu, X., Long, Q., Tian, F., Long, X., & Li, Y. (2024). Safety and Efficacy of the Modified Vaccinia Ankara–Bavaria Nordic Vaccine Against Mpox in the Real World: Systematic Review and Meta-Analysis. Viral Immunology. https://doi.org/10.1089/vim.2023.0147

Vancouver

Pang Y, Cao D, Zhu X, Long Q, Tian F, Long X, et al. Safety and Efficacy of the Modified Vaccinia Ankara–Bavaria Nordic Vaccine Against Mpox in the Real World: Systematic Review and Meta-Analysis. Viral Immunology. 2024. doi:10.1089/vim.2023.0147

BibTeX
@article{Pang2024,
  author = {Pang, Yi and Cao, Demin and Zhu, Xiaoying and Long, Qinqin and Tian, Fengqin and Long, Xidai and Li, Yulei},
  title = {Safety and Efficacy of the Modified Vaccinia Ankara–Bavaria Nordic Vaccine Against Mpox in the Real World: Systematic Review and Meta-Analysis},
  journal = {Viral Immunology},
  year = {2024},
  doi = {10.1089/vim.2023.0147}
}
Kostenlos starten →